Empaglif (Empagliflozin)

Empagliflozin Description Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, Empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion. Presentation Empaglif 10 […]

Empaglif-M (Empagliflozin INN & Metformin Hydrochloride BP)

Empagliflozin INN & Metformin Hydrochloride BP Empaglif-M combines 2 anti-hyperglycemic agents with complementary mechanisms of action to improve glycemic control in patients with type 2 diabetes: Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin, a member of the biguanide class. Description Empagliflozin: Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of […]

Epinast (Epinastine Hydrochloride)

Description Epinastine is a topically active antihistamine that antagonizes both histamine H1 and H2 receptors. Moreover, it has mast cell stabilizing activity and prevents the release of inflammatory mediators from blood vessel. Epinastine does not penetrate the blood-brain barrier and therefore is not expected to induce side effects of the central nervous system. Presentation Epinast […]

Erdon Eye Drop (Diclofenac)

Erdon contains diclofenac sodium, a non-steroidal substance with anti-inflammatory and analgesic effects. Inhibition of prostaglandin synthesis, which has been demonstrated in experiments, is considered to be fundamental to the mechanism of action of diclofenac. Prostaglandin plays a major role in the pathogenesis of inflammation and pain. Erdon has an anti-inflammatory effect when given after surgery […]

ERTINIB (Erlotinib Hydrochloride)

Ertinib (Erlotinib) tablet contains 100 mg or 150 mg of Erlotinib which is a tyrosine kinase inhibitor. Description Epidermal growth factor receptor (EGFR) is expressed on the cell surface of both normal and cancer cells. In some tumor cells signaling through this receptor plays a role in tumor cell survival and proliferation. Erlotinib reversibly inhibits the kinase […]

Etovan (Etoricoxib)

Description Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic, and antipyretic activities. Etoricoxib is a potent, orally active & highly selective cyclooxygenase-2 (COX-2) inhibitor. COX-2 is primarily responsible for the synthesis of prostanoid mediators of pain, inflammation and fever. Etoricoxib decreases these clinical signs and symptoms effectively with decreased GI toxicity. Moreover […]

Expecto (Bromhexine HCl BP)

Description Expecto (Bromhexine HCl) is a highly effective mucolytic Expectorant. Presentation Expecto Syrup: Each 5 ml syrup contains Bromhexine Hydrochloride BP 4 mg. Indications Expecto (Bromhexine HCl) is indicated in the treatment of respiratory disorders associated with productive cough. Expecto also helps to clear the chest by thinning the mucus in air passages. Dosage & Administration […]

Extracef (Cefradine)

Description Cefradine, which is the most stable first generation Cephalosporin antibiotic, is active against all types of beta-lactamase producing bacteria. Cefradine is a broad spectrum bactericidal antibiotic active against a wide range of infections caused by susceptible Gram-negative and Gram-positive organisms. Presentation Extracef-250 Capsule: Each capsule contains Cefradine BP 250 mg.Extracef-500 Capsule: Each capsule contains […]

Erdon (Diclofenac)

Diclofenac is a potent NSAID having both strong anti-inflammatory & analgesic properties. It inhibits synthesis of prostaglandin from arachidonic acid by blocking the cycloxygenase enzyme. Presentation Erdon-100 TR Capsule: Each capsule contains timed release Diclofenac Sodium pellets equivalent to Diclofenac Sodium BP 100 mg.Erdon Gel: Each gram gel contains Diclofenac Diethylamine BP equivalent to Diclofenac […]

Febux (Febuxostat)

Description Febuxostat is a non-purine, selective xanthine oxidase (XO) inhibitor. It decreases serum uric acid level by inhibiting xanthine oxidase, which is responsible for uric acid production. Xanthine oxidase breaks down hypoxanthine to xanthine and thus to uric acid. Febuxostat is not expected to inhibit other enzymes involved in purine and pyrimidine synthesis and metabolism […]